# Ovid Therapeutics Inc.: Form 8-K, filed Dec 6, 2023

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2023-12-06
- Accepted by EDGAR: Dec 6, 2023, 17:08 ET
- Period: 2023-12-04
- Accession: 0000950170-23-068591
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/ovid-20231204.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/ovid-20231204.htm

Filed Dec 6, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-068591. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.